CLDN25 Antikörper (Middle Region)

Produktnummer ABIN952690

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch CLDN25 in WB und EIA. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für CLDN25 Antikörper (Middle Region) (ABIN952690)

Target: CLDN25 (Claudin 25 (CLDN25))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CLDN25 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Produktdetails anti-CLDN25 Antikörper

Bindungsspezifität: AA 106-136, Middle Region

Spezifität: This antibody recognizes Human hCG_1646420 (Center).

Aufreinigung: Protein A column, followed by peptide affinity purification

Immunogen: KLH conjugated synthetic peptide between 106-136 amino acids from the Central region of human hCG_1646420.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu CLDN25

Target: CLDN25 (Claudin 25 (CLDN25))

Hintergrund: This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions.Synonyms: CLDN25, Putative claudin-25

Molekulargewicht: 25394 Da

Gen-ID: 644672

NCBI Accession: NP_001094859

Pathways: Hepatitis C